Borosil Scientific Limited

As of June 30, 2026, Borosil Scientific Limited carries a market capitalization of 15.45B, placing it among publicly traded companies globally. Its enterprise value stands at 15.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Borosil Scientific Limited has 88.95M shares outstanding.

As of June 30, 2026, Borosil Scientific Limited trades at a trailing price-to-earnings ratio of 35.93.

As of June 30, 2026, Borosil Scientific Limited trades at an EV/EBITDA multiple of 24.19 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.23 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 34.63 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 15.45B versus a market cap of 15.45B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.95M in revenue per employee across its workforce of 1,620.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Borosil Scientific Limited recorded 97.61M in income tax expense. That works out to an effective tax rate of 18.45, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 529.07M, leaving 431.49M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Borosil Scientific Limited's stock has declined approximately 22.24% over the past 52 weeks. The 50-day moving average sits at 120.66, while the 200-day moving average is 126.12.

Over the twelve months ended June 30, 2026, Borosil Scientific Limited generated 4.78B in revenue and converted that into 431.49M in net income, yielding earnings per share of 4.83. EBITDA reached 638.62M, while operating income came in at 465.27M.

Over the twelve months ended June 30, 2026, Borosil Scientific Limited posted a gross margin of 65.36, reflecting its pricing power and cost economics. The operating margin of 9.73 and net profit margin of 9.02 provide insight into operational efficiency.